Literature DB >> 2233076

Computed tomography staging of the paranasal sinuses in chronic hyperplastic rhinosinusitis.

W H Friedman1, G P Katsantonis, M Sivore, S Kay.   

Abstract

In this study, the computed tomography scans of 100 patients with chronic hyperplastic rhinosinusitis were reviewed to establish a clinical staging system. Fourteen percent of the patients were classified as Stage I (single-focus disease); 36% as Stage II (multifocal disease responsive to conservative therapy); 32% as Stage III (diffuse disease partially responsive to medication); and 16% as Stage IV (diffuse disease associated with bony changes and poorly responsive to conservative treatment). The incidence of recurrent or persistent disease ranged from 13% for Stage II to 30% for Stage IV. Stage I and III patients had 13% and 18% recurrence rates, respectively. Computed tomography staging is shown to be useful in outlining operative strategies and is a reliable prognosticator of the disease process.

Entities:  

Mesh:

Year:  1990        PMID: 2233076     DOI: 10.1288/00005537-199011000-00005

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  The Utility of Radiologic Studies in the Diagnosis and Management of Rhinosinusitis.

Authors:  Andrew H. Marshall; Nick S. Jones
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

Review 2.  Recent trends in the diagnosis and treatment of sinusitis.

Authors:  M Jorissen
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Endoscopic sinus surgery in children with chronic sinus disease failed on medical management.

Authors:  Y Kansal; N N Mathur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2001-07

4.  A new score for tomographic opacification of paranasal sinuses in children.

Authors:  Severino Aires de Araújo Neto; Emílio Carlos Elias Baracat; Leonardo Franco Felipe
Journal:  Braz J Otorhinolaryngol       Date:  2010 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.